230 related articles for article (PubMed ID: 12417358)
1. Patient populations in clinical trials of the efficacy and tolerability of donepezil in patients with vascular dementia.
Pratt RD
J Neurol Sci; 2002 Nov; 203-204():57-65. PubMed ID: 12417358
[TBL] [Abstract][Full Text] [Related]
2. Patient populations in clinical studies of donepezil in vascular dementia.
Pratt RD
Int Psychogeriatr; 2003; 15 Suppl 1():195-200. PubMed ID: 16191240
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial.
Black S; Román GC; Geldmacher DS; Salloway S; Hecker J; Burns A; Perdomo C; Kumar D; Pratt R;
Stroke; 2003 Oct; 34(10):2323-30. PubMed ID: 12970516
[TBL] [Abstract][Full Text] [Related]
4. Donepezil in vascular dementia: a randomized, placebo-controlled study.
Wilkinson D; Doody R; Helme R; Taubman K; Mintzer J; Kertesz A; Pratt RD;
Neurology; 2003 Aug; 61(4):479-86. PubMed ID: 12939421
[TBL] [Abstract][Full Text] [Related]
5. Donepezil for vascular cognitive impairment.
Malouf R; Birks J
Cochrane Database Syst Rev; 2004; (1):CD004395. PubMed ID: 14974068
[TBL] [Abstract][Full Text] [Related]
6. Comparison of different clinical criteria (DSM-III, ADDTC, ICD-10, NINDS-AIREN, DSM-IV) for the diagnosis of vascular dementia. National Institute of Neurological Disorders and Stroke-Association Internationale pour la Recherche et l'Enseignement en Neurosciences.
Pohjasvaara T; Mäntylä R; Ylikoski R; Kaste M; Erkinjuntti T
Stroke; 2000 Dec; 31(12):2952-7. PubMed ID: 11108755
[TBL] [Abstract][Full Text] [Related]
7. Cognitive, global, and functional benefits of donepezil in Alzheimer's disease and vascular dementia: results from large-scale clinical trials.
Passmore AP; Bayer AJ; Steinhagen-Thiessen E
J Neurol Sci; 2005 Mar; 229-230():141-6. PubMed ID: 15760632
[TBL] [Abstract][Full Text] [Related]
8. Randomized, placebo-controlled, clinical trial of donepezil in vascular dementia: differential effects by hippocampal size.
Román GC; Salloway S; Black SE; Royall DR; Decarli C; Weiner MW; Moline M; Kumar D; Schindler R; Posner H
Stroke; 2010 Jun; 41(6):1213-21. PubMed ID: 20395618
[TBL] [Abstract][Full Text] [Related]
9. Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL.
Dichgans M; Markus HS; Salloway S; Verkkoniemi A; Moline M; Wang Q; Posner H; Chabriat HS
Lancet Neurol; 2008 Apr; 7(4):310-8. PubMed ID: 18296124
[TBL] [Abstract][Full Text] [Related]
10. Dementia with cerebrovascular disease: the benefits of early treatment.
Schindler RJ
Eur J Neurol; 2005 Oct; 12 Suppl 3():17-21. PubMed ID: 16144533
[TBL] [Abstract][Full Text] [Related]
11. Treating dementia patients with vascular lesions with donepezil: a preliminary analysis.
Thomas DA; Libon DJ; Ledakis GE
Appl Neuropsychol; 2005; 12(1):12-8. PubMed ID: 15788218
[TBL] [Abstract][Full Text] [Related]
12. Donepezil treatment of vascular dementia.
Meyer JS; Chowdhury MH; Xu G; Li YS; Quach M
Ann N Y Acad Sci; 2002 Nov; 977():482-6. PubMed ID: 12480789
[TBL] [Abstract][Full Text] [Related]
13. P300 auditory event-related potentials and neuropsychological study during donepezil treatment in vascular dementia.
Paci C; Gobbato R; Carboni T; Sanguigni S; Santone A; Curatola L
Neurol Sci; 2006 Feb; 26(6):435-7. PubMed ID: 16601937
[TBL] [Abstract][Full Text] [Related]
14. Defining dementia: clinical criteria for the diagnosis of vascular dementia.
Román GC
Acta Neurol Scand Suppl; 2002; 178():6-9. PubMed ID: 12492785
[TBL] [Abstract][Full Text] [Related]
15. Treatment of vascular dementia--evidence from clinical trials with cholinesterase inhibitors.
Erkinjuntti T; Román G; Gauthier S
J Neurol Sci; 2004 Nov; 226(1-2):63-6. PubMed ID: 15537522
[TBL] [Abstract][Full Text] [Related]
16. Classification of vascular dementia in the Cardiovascular Health Study Cognition Study.
Lopez OL; Kuller LH; Becker JT; Jagust WJ; DeKosky ST; Fitzpatrick A; Breitner J; Lyketsos C; Kawas C; Carlson M
Neurology; 2005 May; 64(9):1539-47. PubMed ID: 15883314
[TBL] [Abstract][Full Text] [Related]
17. Clinical trials of propentofylline in vascular dementia. European/Canadian Propentofylline Study Group.
Kittner B
Alzheimer Dis Assoc Disord; 1999; 13 Suppl 3():S166-71. PubMed ID: 10609697
[TBL] [Abstract][Full Text] [Related]
18. Coexisting cerebral infarction in Alzheimer's disease is associated with fast dementia progression: applying the National Institute for Neurological Disorders and Stroke/Association Internationale pour la Recherche et l'Enseignement en Neurosciences Neuroimaging Criteria in Alzheimer's Disease with Concomitant Cerebral Infarction.
Sheng B; Cheng LF; Law CB; Li HL; Yeung KM; Lau KK
J Am Geriatr Soc; 2007 Jun; 55(6):918-22. PubMed ID: 17537094
[TBL] [Abstract][Full Text] [Related]
19. The ASCOMALVA trial: association between the cholinesterase inhibitor donepezil and the cholinergic precursor choline alphoscerate in Alzheimer's disease with cerebrovascular injury: interim results.
Amenta F; Carotenuto A; Fasanaro AM; Rea R; Traini E
J Neurol Sci; 2012 Nov; 322(1-2):96-101. PubMed ID: 22959283
[TBL] [Abstract][Full Text] [Related]
20. Donepezil in vascular dementia: combined analysis of two large-scale clinical trials.
Román GC; Wilkinson DG; Doody RS; Black SE; Salloway SP; Schindler RJ
Dement Geriatr Cogn Disord; 2005; 20(6):338-44. PubMed ID: 16192723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
